tiprankstipranks
Trending News
More News >
Fusen Pharmaceutical Co., Ltd. (HK:1652)
:1652
Hong Kong Market

Fusen Pharmaceutical Co., Ltd. (1652) Income Statement

Compare
0 Followers

Fusen Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q4 2024), Fusen Pharmaceutical Co., Ltd.'s total revenue was ¥64.85M, a decrease of -43.40% from the same quarter last year. In Q4, Fusen Pharmaceutical Co., Ltd.'s net income was ¥-75.92M. See Fusen Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 326.03M¥ 565.61M¥ 491.76M¥ 385.66M¥ 486.85M
Gross Profit
¥ 162.64M¥ 299.51M¥ 225.02M¥ 211.13M¥ 266.07M
Operating Expenses
¥ 230.15M¥ 279.49M¥ 186.41M¥ 146.65M¥ 181.83M
Depreciation and Amortization
¥ 28.10M¥ 35.80M¥ 34.16M¥ 23.79M¥ 22.46M
EBITDA
¥ -39.07M¥ 18.93M¥ 49.90M¥ 86.84M¥ 110.30M
Operating Income
¥ -67.51M¥ 20.02M¥ 15.74M¥ 52.14M¥ 103.22M
Other Income/Expenses
¥ -122.94M¥ -49.46M¥ -74.75M¥ -28.35M¥ -24.81M
Pretax Income
¥ -190.45M¥ -29.45M¥ -30.99M¥ 23.79M¥ 78.41M
Net Income
¥ -188.78M¥ -36.28M¥ -34.65M¥ 16.64M¥ 70.13M
Per Share Metrics
Basic EPS
¥ -0.26¥ -0.05¥ -0.05¥ 0.02¥ 0.09
Diluted EPS
¥ -0.26¥ -0.05¥ -0.05¥ 0.02¥ 0.09
Weighted Average Shares Outstanding
739.98M 725.54M 756.07M 769.62M 786.08M
Weighted Average Shares Outstanding (Diluted)
739.98M 752.06M 756.07M 770.31M 790.16M
Currency in CNY

Fusen Pharmaceutical Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis